LINC01618: A Potential Drug Target and Biomarker (G152578)

Target Name: LINC01618

NCBI ID: G152578

LINC01618

Other Name(s): long intergenic non-protein coding RNA 1618 | Long intergenic non-protein coding RNA 1618

LINC01618: A Potential Drug Target and Biomarker

LINC01618 is a long intergenic non-protein coding RNA (lncRNA) with a length of approximately 290 nucleotides. It is located between the exons 21 and 22 of the human chromosome 16 and is expressed in various tissues and cells of the body.

Recent studies have identified LINC01618 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and mental health conditions.

One of the reasons for the potential drug targeting of LINC01618 is its unique structure and expression pattern. LINC01618 is a non-coding RNA that is highly conserved across various species, meaning that it has similar patterns of expression in different organisms. This conservation allows researchers to study its function and potential interactions with other molecules.

Additionally, LINC01618 has been shown to play a role in several cellular processes that are important for human health and disease. For example, LINC01618 has been shown to be involved in cell adhesion, migration, and the development of cancer. It has also been linked to several neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

Another potential drug target for LINC01618 is its expression pattern in different tissues and organs. LINC01618 is expressed in various tissues of the body, including the brain, heart, and pancreas, and has been shown to be involved in the development and progression of these diseases. This suggests that LINC01618 may be a useful biomarker for these conditions.

Finally, LINC01618 has also been shown to be involved in the regulation of gene expression. This suggests that it may be a potential drug target for diseases that are characterized by disruptions in gene expression.

In conclusion, LINC01618 is a unique and promising candidate for drug targeting and biomarker development. Its conservation in different species, its involvement in several cellular processes, its expression pattern in different tissues, and its potential as a regulator of gene expression make it an attractive target for research and development of new treatments for various diseases. Further studies are needed to fully understand its functions and potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1618

The "LINC01618 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01618 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets